Cite
Genetic and Clinical Factors Associated with Olokizumab Treatment in Russian Patients with Rheumatoid Arthritis.
MLA
Mikhaylenko, Dmitry S., et al. “Genetic and Clinical Factors Associated with Olokizumab Treatment in Russian Patients with Rheumatoid Arthritis.” Journal of Personalized Medicine, vol. 12, no. 4, Apr. 2022, p. 641. EBSCOhost, https://doi.org/10.3390/jpm12040641.
APA
Mikhaylenko, D. S., Kuznetsova, E. B., Musatova, V. V., Bure, I. V., Deryagina, T. A., Alekseeva, E. A., Tarasov, V. V., Zamyatnin Jr., A. A., & Nemtsova, M. V. (2022). Genetic and Clinical Factors Associated with Olokizumab Treatment in Russian Patients with Rheumatoid Arthritis. Journal of Personalized Medicine, 12(4), 641. https://doi.org/10.3390/jpm12040641
Chicago
Mikhaylenko, Dmitry S., Ekaterina B. Kuznetsova, Viktoria V. Musatova, Irina V. Bure, Tatiana A. Deryagina, Ekaterina A. Alekseeva, Vadim V. Tarasov, Andrey A. Zamyatnin Jr., and Marina V. Nemtsova. 2022. “Genetic and Clinical Factors Associated with Olokizumab Treatment in Russian Patients with Rheumatoid Arthritis.” Journal of Personalized Medicine 12 (4): 641. doi:10.3390/jpm12040641.